Description
PT-141 is the commonly used developmental name associated with bremelanotide, a melanocortin receptor agonist. A regulated prescription formulation has an approved indication in certain jurisdictions. Research-grade or differently formulated products should not be represented as equivalent to an approved pharmaceutical product.

Reviews
There are no reviews yet.